Davita Inc vs Block Inc — how do they compare? Davita Inc trades at $178.47 (market cap $11.38B), while Block Inc trades at $77.43 (market cap $47.50B). The key difference: Block Inc is far larger — about 4.2× Davita Inc's market cap, and Block Inc is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | XYZ | |
|---|---|---|
Market Cap | $11.38B | $47.50B |
Sector | Health | Technology |
52-Week High | $240.96 | $84.64 |
52-Week Low | $103.87 | $49.04 |
Enterprise Value | $24.10B | $42.41B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
XYZ stock trades at $78.98, down slightly by 0.03% today, with a bullish technical signal and strong support at $78. Recent Q2 2026 earnings beat expectations with EPS of $1.02 versus $0.871, driven by 25% gross profit growth in Cash App and Square. The company raised its 2026 profit outlook, and analyst consensus is strongly bullish with a $99.47 price target. However, the P/E ratio of 141.2 reflects high valuation expectations.
The outlook is positive given raised guidance and AI-driven efficiency gains, but risks include high valuation multiples and net cash outflows. Investment appeal hinges on sustained profit growth from Cash App and Square monetization, though margin compression and competitive pressures remain key watchpoints for investors.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →